Skip to content
Research Article Open access CC BY 4.0

Cryptosporidiosis: A Potential Anti-diarrheal Natural Product Drug Discovery Journey in Ghana, West Africa

Senyo K. Botchie, Andrew G. Mtewa, Irene Ayi

Journal of Scientific Research and Reports · pp. 85–93 · Published 4 Dec 2020

10.9734/jsrr/2020/v26i930311

Abstract

The overwhelming resistance to current drugs and the exhaustion of drug development interventions, as well as synthetic libraries, have compelled researchers to resort to the use of novel drug candidates derived from natural products. Cryptosporidium, the causative organism of Cryptosporidiosis, is no exception. The diarrhea-causing parasite is known to be the leading cause of deaths in children below age 5 in developing countries like Ghana and second to rotavirus as the causative agent for diarrhea in newborn calves and infants. Currently, the only FDA approved drug for the treatment of Cryptosporidiosis is Nitazoxanide. It is, therefore, needful to develop novel alternative candidates as it could aid in the decrease in child mortality and malnutrition in developing countries. Even though there have been significant limitations into anti-cryptosporidial drug development in vitro and in vivo, essential advancements are being made of which this article addresses the need for research into natural products. Some studies outlined in this paper has stated potential plant extracts showing anti-cryptosporidiosis efficacy. With the wealth of medicinal plant products and Cryptosporidium in vitro culture expertise available in our labs at Noguchi Memorial Institute for Medical research we are certain of making potential significant strides in the world of natural product Cryptosporidium drug discovery in Africa.

Drug discovery Cryptosporidium natural products drug candidates diarrhea computational drug discovery.

References (19)

  1. 1 Drug Discovery and Natural Products: End of an Era or an Endless Frontier? [DOI]
  2. 2 Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery [DOI]
  3. 3 Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review [DOI]
  4. 4 Mangifera Indica (Mango) [DOI]
  5. 5 High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial [DOI]
  6. 6 A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis [DOI]
  7. 7 Artemisia afra: A potential flagship for African medicinal plants? [DOI]
  8. 8 Identification of Cryptosporidium parvum Active Chemical Series by Repurposing the Open Access Malaria Box [DOI]
  9. 9 Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines [DOI]
  10. 10 Cryptosporidium parvum IMP Dehydrogenase [DOI]
  11. 11 Efficacy ofAllium sativum(garlic) against experimental cryptosporidiosis [DOI]
  12. 12 Efficacy of Allium sativum (garlic) in controlling nematode parasites in sheep.
  13. 13 Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells [DOI]
  14. 14 Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture [DOI]
  15. 15 Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model [DOI]
  16. 16 Amelioration of Cryptosporidium parvum Infection In Vitro and In Vivo by Targeting Parasite Fatty Acyl-Coenzyme A Synthetases [DOI]
  17. 17 Cryptosporidium Spp., a Frequent Cause of Diarrhea among Children at the Korle-Bu Teaching Hospital, Accra, Ghana [DOI]
  18. 18 Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans [DOI]
  19. 19 The effect of blueberry extracts on Giardia duodenalis viability and spontaneous excystation of Cryptosporidium parvum oocysts, in vitro [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

60

Page views

0

PDF downloads

24

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.